University of Newcastle Experts Warn of 'Nutritional Blind Spot' in Popular Weight-Loss Drugs
February 04, 2026
February 04, 2026
CALLAGHAN, Australia, Feb. 4 -- The University of Newcastle posted the following news:
* * *
Yes, weight-loss drugs work but nutrition needs attention
Popular GLP-1 and GIP medications, such as semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro) and liraglutide (Saxenda) are changing the way obesity and type 2 diabetes are viewed and treated.
* GLP-1 and GIP medications are effective for weight-related health management, but their impact on . . .
* * *
Yes, weight-loss drugs work but nutrition needs attention
Popular GLP-1 and GIP medications, such as semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro) and liraglutide (Saxenda) are changing the way obesity and type 2 diabetes are viewed and treated.
* GLP-1 and GIP medications are effective for weight-related health management, but their impact on . . .